We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$72.6B
AUM Growth
+$7.53B
Cap. Flow
+$3.73B
Cap. Flow %
5.13%
Top 10 Hldgs %
9.55%
Holding
3,940
New
507
Increased
1,441
Reduced
1,273
Closed
394

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$434M
2
NFLX icon
Netflix
NFLX
+$301M
3
BABA icon
Alibaba
BABA
+$245M
4
VZ icon
Verizon
VZ
+$235M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Technology 13.27%
2 Healthcare 11.28%
3 Consumer Discretionary 8.99%
4 Communication Services 8.03%
5 Industrials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
1301
CALL
Teva Pharmaceuticals
TEVA
$36.2B
$6.26M 0.01%
330,600
+150,500
+84% +$2.26M
IP icon
1302
International Paper
IP
$22.5B
$6.26M 0.01%
+114,122
New +$6.13M
PII icon
1303
PUT
Polaris
PII
$4.25B
$6.26M 0.01%
50,500
BRX icon
1304
Brixmor Property Group
BRX
$9.93B
$6.25M 0.01%
335,130
-361,613
-52% -$6.61M
GIS icon
1305
PUT
General Mills
GIS
$19.5B
$6.24M 0.01%
105,200
TFX icon
1306
CALL
Teleflex
TFX
$5.8B
$6.22M 0.01%
25,000
+15,000
+150% +$3.77M
TVTX icon
1307
Travere Therapeutics
TVTX
$5.27B
$6.21M 0.01%
294,942
+135,761
+85% +$3.1M
DBD
1308
DELISTED
Diebold Nixdorf Incorporated
DBD
$6.21M 0.01%
380,031
+291,022
+327% +$5.63M
AIG icon
1309
PUT
American International
AIG
$42B
$6.19M 0.01%
103,900
+53,900
+108% +$3.31M
INTU icon
1310
Intuit
INTU
$83.1B
$6.18M 0.01%
39,176
-96,810
-71% -$14.8M
WBA
1311
CALL
DELISTED
Walgreens Boots Alliance
WBA
$6.17M 0.01%
85,000
+45,000
+113% +$3.17M
EBSB
1312
DELISTED
Meridian Bancorp, Inc.
EBSB
$6.17M 0.01%
299,268
-6,524
-2% -$129K
JOYY
1313
CALL
JOYY Inc
JOYY
$3.77B
$6.16M 0.01%
54,500
-20,000
-27% -$2.01M
RTN
1314
PUT
DELISTED
Raytheon Company
RTN
$6.16M 0.01%
32,800
+1,800
+6% +$336K
TTC icon
1315
Toro Company
TTC
$9.01B
$6.14M 0.01%
94,118
+46,411
+97% +$2.94M
DLR icon
1316
CALL
Digital Realty Trust
DLR
$72.4B
$6.13M 0.01%
53,800
BWLD
1317
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$6.12M 0.01%
39,133
-13,639
-26% -$1.8M
PAYX icon
1318
CALL
Paychex
PAYX
$41.1B
$6.11M 0.01%
89,700
+19,700
+28% +$1.29M
MTN icon
1319
Vail Resorts
MTN
$5.28B
$6.1M 0.01%
+28,714
New +$6.43M
PRGO icon
1320
PUT
Perrigo
PRGO
$1.4B
$6.1M 0.01%
70,000
ABUS icon
1321
Arbutus Biopharma
ABUS
$871M
$6.09M 0.01%
1,206,125
-547,980
-31% -$3.21M
NDSN icon
1322
Nordson
NDSN
$16.6B
$6.08M 0.01%
41,556
+36,112
+663% +$4.64M
MTRX icon
1323
Matrix Service
MTRX
$347M
$6.08M 0.01%
341,535
-133,794
-28% -$2.1M
SYF icon
1324
PUT
Synchrony
SYF
$24.5B
$6.08M 0.01%
157,400
MEDP icon
1325
Medpace
MEDP
$16.5B
$6.06M 0.01%
167,033
+101,341
+154% +$3.55M

Similar funds

D.E. Shaw & Co's Q4 2017 Portfolio in Review

As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $434M trimmed.

  • D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
  • D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
  • D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
  • D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
  • D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
  • D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.